351 related articles for article (PubMed ID: 24586047)
1. Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.
Sutherland KD; Song JY; Kwon MC; Proost N; Zevenhoven J; Berns A
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4952-7. PubMed ID: 24586047
[TBL] [Abstract][Full Text] [Related]
2. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma.
Xu X; Rock JR; Lu Y; Futtner C; Schwab B; Guinney J; Hogan BL; Onaitis MW
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4910-5. PubMed ID: 22411819
[TBL] [Abstract][Full Text] [Related]
3. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model.
Moghaddam SJ; Li H; Cho SN; Dishop MK; Wistuba II; Ji L; Kurie JM; Dickey BF; Demayo FJ
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):443-53. PubMed ID: 18927348
[TBL] [Abstract][Full Text] [Related]
4. Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.
Mainardi S; Mijimolle N; Francoz S; Vicente-Dueñas C; Sánchez-García I; Barbacid M
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):255-60. PubMed ID: 24367082
[TBL] [Abstract][Full Text] [Related]
5. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
Kasinski AL; Slack FJ
Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
[TBL] [Abstract][Full Text] [Related]
6. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.
Nagaraj AS; Lahtela J; Hemmes A; Pellinen T; Blom S; Devlin JR; Salmenkivi K; Kallioniemi O; Mäyränpää MI; Närhi K; Verschuren EW
Cell Rep; 2017 Jan; 18(3):673-684. PubMed ID: 28099846
[TBL] [Abstract][Full Text] [Related]
7. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
[TBL] [Abstract][Full Text] [Related]
8. Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.
Duan W; Gao L; Kalvala A; Aguila B; Brooks C; Mo X; Ding H; Shilo K; Otterson GA; Villalona-Calero MA
Int J Cancer; 2019 Nov; 145(9):2418-2426. PubMed ID: 30873587
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
Cho HC; Lai CY; Shao LE; Yu J
Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
[TBL] [Abstract][Full Text] [Related]
10. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
[TBL] [Abstract][Full Text] [Related]
11. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.
Pan Y; Jiang Y; Tan L; Ravoori MK; Gagea M; Kundra V; Fischer SM; Yang P
Oncotarget; 2015 Nov; 6(36):38816-26. PubMed ID: 26452035
[TBL] [Abstract][Full Text] [Related]
12. Alveolar type II cells possess the capability of initiating lung tumor development.
Lin C; Song H; Huang C; Yao E; Gacayan R; Xu SM; Chuang PT
PLoS One; 2012; 7(12):e53817. PubMed ID: 23285300
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.
Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD
Toxicology; 2003 May; 187(2-3):217-28. PubMed ID: 12699910
[TBL] [Abstract][Full Text] [Related]
14.
Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC
Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981
[No Abstract] [Full Text] [Related]
15. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.
Meuwissen R; Linn SC; van der Valk M; Mooi WJ; Berns A
Oncogene; 2001 Oct; 20(45):6551-8. PubMed ID: 11641780
[TBL] [Abstract][Full Text] [Related]
16. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
Deng H; Ge H; Dubey C; Losmanova T; Medová M; Konstantinidou G; Mutlu SM; Birrer FE; Brodie TM; Stroka D; Wang W; Peng RW; Dorn P; Marti TM
Cancer Immunol Immunother; 2023 Dec; 72(12):4457-4470. PubMed ID: 37796299
[TBL] [Abstract][Full Text] [Related]
17. Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer.
Best SA; Kersbergen A; Asselin-Labat ML; Sutherland KD
Methods Mol Biol; 2018; 1725():15-29. PubMed ID: 29322405
[TBL] [Abstract][Full Text] [Related]
18. Early detection of pre-malignant lesions in a KRAS
Rakhit CP; Trigg RM; Le Quesne J; Kelly M; Shaw JA; Pritchard C; Martins LM
Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30760495
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
Volonte D; Vyas AR; Chen C; Dacic S; Stabile LP; Kurland BF; Abberbock SR; Burns TF; Herman JG; Di YP; Galbiati F
J Biol Chem; 2018 Feb; 293(5):1794-1809. PubMed ID: 29247004
[TBL] [Abstract][Full Text] [Related]
20. Activating the expression of human K-rasG12D stimulates oncogenic transformation in transgenic goat fetal fibroblast cells.
Gong J; Wang Z; Polejaeva I; Salgia R; Kao CM; Chen CT; Chen G; Chen L
PLoS One; 2014; 9(3):e90059. PubMed ID: 24594684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
